Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Jun;67(6):1623–1629. doi: 10.1172/JCI110197

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

Heinz W Radtke 1,2,3, Arvind B Rege 1,2,3, Max B Lamarche 1,2,3, Dagmar Bartos 1,2,3, Frantisek Bartos 1,2,3, Robert A Campbell 1,2,3, James W Fisher 1,2,3
PMCID: PMC370736  PMID: 7240411

Abstract

Fetal mouse liver and normal human bone marrow cell cultures were used for studies on the inhibition of erythroid colony formation (CFU-E) by sera from anemic patients with end-stage renal failure and the polyamine spermine. Sera from each of eight predialysis uremic anemic patients with end-stage renal failure produced a significant (P < 0.001) inhibition of erythroid colony formation in the fetal mouse liver cell cultures when compared to sera from normal human volunteers. In vivo or in vitro dialysis of the uremic sera with a 3,500-dalton exclusion limit membrane removed the inhibitor from uremic sera. The uremic serum dialysate provided by the membrane fractionation was significantly inhibitory in the erythroid cell cultures. When this dialysate was applied to gel filtration chromatography (Bio-Gel P-2) the inhibitor was found to be in the same molecular weight range as [14C]spermine. The polyamine spermine produced a dose-related inhibition of erythroid colony formation (CFU-E) in fetal mouse liver and normal human bone marrow cultures. Thus, the following evidence is provided that the in vitro inhibitor of erythropoiesis found in chronic renal failure patients' sera is identical with the polyamine spermine: (a) the inhibitor and radiolabeled spermine appeared in identical Bio-Gel P-2 effluent fractions; (b) when spermine was added to normal human sera at concentrations reported in sera of uremic patients, and studied in both the fetal mouse liver cell culture and normal human bone marrow cultures, a dose-related inhibition of erythroid colony (CFU-E) formation was noted; and (c) the inhibitory effects of crude uremic serum, uremic serum dialysate, and fractions of uremic serum dialysate from a Bio-Gel column, on erythroid colony formation were completely abolished by the addition of a specific rabbit antiserum to spermine.

Full text

PDF
1623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergström J., Fürst P. Uremic toxins. Kidney Int Suppl. 1978 Jun;(8):S9–12. [PubMed] [Google Scholar]
  2. CALLEN I. R., LIMARZI L. R. Blood and bone marrow studies in renal disease. Am J Clin Pathol. 1950 Jan;20(1):3-23, illust. doi: 10.1093/ajcp/20.1.3. [DOI] [PubMed] [Google Scholar]
  3. CHENEY K., BONNIN J. A. Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol. 1962 Jul;8:215–222. doi: 10.1111/j.1365-2141.1962.tb06514.x. [DOI] [PubMed] [Google Scholar]
  4. Caro J., Brown S., Miller O., Murray T., Erslev A. J. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med. 1979 Mar;93(3):449–458. [PubMed] [Google Scholar]
  5. Chun P. W., Rennert O. M., Saffen E. E., Taylor W. J. Effect of polyamines on the electrokinetic properties of red blood cells. Biochem Biophys Res Commun. 1976 Apr 19;69(4):1095–1101. doi: 10.1016/0006-291x(76)90485-x. [DOI] [PubMed] [Google Scholar]
  6. Gahl W. A., Changus J. E., Pitot H. C. The effect of spermidine and spermine on proliferation in vitro of fibroblasts from normal and cystic fibrosis patients. Pediatr Res. 1976 May;10(5):531–535. doi: 10.1203/00006450-197605000-00005. [DOI] [PubMed] [Google Scholar]
  7. Iscove N. N., Sieber F., Winterhalter K. H. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol. 1974 Apr;83(2):309–320. doi: 10.1002/jcp.1040830218. [DOI] [PubMed] [Google Scholar]
  8. KAYE M. The anemia associated with renal disease. J Lab Clin Med. 1958 Jul;52(1):83–100. [PubMed] [Google Scholar]
  9. Lertora J. J., Dargon P. A., Rege A. B., Fisher J. W. Studies on a radioimmunoassay for human erythopoietin. J Lab Clin Med. 1975 Jul;86(1):140–151. [PubMed] [Google Scholar]
  10. MARKSON J. L., RENNIE J. B. The anaemia of chronic renal insufficiency; the effect of serum from azotaemic patients on the maturation of normoblasts in suspension cultures. Scott Med J. 1956 Oct;1(10):320–322. doi: 10.1177/003693305600101003. [DOI] [PubMed] [Google Scholar]
  11. MASON E. E. Gastrointestinal lesions occurring in uremia. Ann Intern Med. 1952 Jul;37(1):96–105. doi: 10.7326/0003-4819-37-1-96. [DOI] [PubMed] [Google Scholar]
  12. Moriyama Y., Rege A., Fisher J. W. Studies on an inhibitor of erythropoiesis. II. Inhibitory effects of serum from uremic rabbits on heme synthesis in rabbit bone marrow cultures (38483). Proc Soc Exp Biol Med. 1975 Jan;148(1):94–97. doi: 10.3181/00379727-148-38483. [DOI] [PubMed] [Google Scholar]
  13. Ogawa M., Parmley R. T., Bank H. L., Spicer S. S. Human marrow erythropoiesis in culture. I. Characterization of methylcellulose colony assay. Blood. 1976 Sep;48(3):407–417. [PubMed] [Google Scholar]
  14. Ohno Y., Rege A. B., Fisher J. W., Barona J. Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotemic patients with anemia of renal disease. J Lab Clin Med. 1978 Dec;92(6):916–923. [PubMed] [Google Scholar]
  15. RATH C. E., MAILLIARD J. A., SCHREINER G. E. Bleeding tendency in uremia. N Engl J Med. 1957 Oct 24;257(17):808–811. doi: 10.1056/NEJM195710242571704. [DOI] [PubMed] [Google Scholar]
  16. Radtke H. W., Claussner A., Erbes P. M., Scheuermann E. H., Schoeppe W., Koch K. M. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. 1979 Oct;54(4):877–884. [PubMed] [Google Scholar]
  17. Radtke H. W., Frei U., Erbes P. M., Schoeppe W., Koch K. M. Improving anemia by hemodialysis: effect of serum erythropoietin. Kidney Int. 1980 Mar;17(3):382–387. doi: 10.1038/ki.1980.44. [DOI] [PubMed] [Google Scholar]
  18. Radtke H. W., Rege A. B., LaMarche M., Fisher J. W. Characterization of erythroid inhibiting factors (EIF) in patients with anemia of chronic renal failure. Proc Clin Dial Transplant Forum. 1979;9:179–183. [PubMed] [Google Scholar]
  19. Shaw A. B. Haemolysis in chronic renal failure. Br Med J. 1967 Apr 22;2(5546):213–216. doi: 10.1136/bmj.2.5546.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Swendseid M. E., Panaqua M., Kopple J. D. Polyamine concentrations in red cells and urine of patients with chronic renal failure. Life Sci. 1980 Feb 18;26(7):533–539. doi: 10.1016/0024-3205(80)90316-1. [DOI] [PubMed] [Google Scholar]
  21. Wallner S. F., Kurnick J. E., Vautrin R., Ward H. P. The effect of serum from uremic patients on erythropoietin. Am J Hematol. 1977;3:45–55. doi: 10.1002/ajh.2830030106. [DOI] [PubMed] [Google Scholar]
  22. Wallner S. F., Kurnick J. E., Ward H. P., Vautrin R., Alfrey A. C. The anemia of chronic renal failure and chronic diseases: in vitro studies of erythropoiesis. Blood. 1976 Apr;47(4):561–569. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES